In this work, we identified five proteins, namely, Gal-1, Gal-9, MMP7, FASLG, and COL9A1, that based on their known function in endometrial and other cancers might represent useful early-stage EC biomarkers, upon a validation phase. Here, FASLG is linked to cancer.